Doximity, Inc. $DOCS Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. reduced its holdings in Doximity, Inc. (NASDAQ:DOCS) by 34.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 218,923 shares of the company’s stock after selling 113,741 shares during the period. Pacer Advisors Inc. owned about 0.12% of Doximity worth $16,014,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Hantz Financial Services Inc. lifted its position in shares of Doximity by 148.9% during the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock valued at $28,000 after buying an additional 271 shares in the last quarter. Toth Financial Advisory Corp raised its position in Doximity by 150.0% during the third quarter. Toth Financial Advisory Corp now owns 500 shares of the company’s stock worth $37,000 after acquiring an additional 300 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Doximity by 176.0% during the first quarter. Smartleaf Asset Management LLC now owns 781 shares of the company’s stock valued at $46,000 after purchasing an additional 498 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Doximity by 196.1% in the third quarter. Farther Finance Advisors LLC now owns 1,134 shares of the company’s stock valued at $83,000 after purchasing an additional 751 shares during the period. Finally, Cullen Frost Bankers Inc. grew its position in shares of Doximity by 29.7% in the second quarter. Cullen Frost Bankers Inc. now owns 1,427 shares of the company’s stock valued at $88,000 after purchasing an additional 327 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. BMO Capital Markets started coverage on shares of Doximity in a research report on Thursday, November 13th. They set a “market perform” rating and a $55.00 price target for the company. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and increased their target price for the company from $75.00 to $82.00 in a report on Monday, October 27th. Canaccord Genuity Group decreased their target price on Doximity from $67.00 to $58.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $62.00 price target on shares of Doximity in a research report on Friday, October 10th. Finally, The Goldman Sachs Group set a $64.00 price objective on Doximity and gave the company a “sell” rating in a research note on Wednesday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, six have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $68.94.

Insider Buying and Selling

In other news, Director Regina M. Benjamin sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the sale, the director owned 19,839 shares in the company, valued at $1,405,394.76. This trade represents a 20.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $66.44, for a total value of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at $1,318,103.16. This represents a 9.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 31.30% of the stock is owned by company insiders.

Doximity Stock Down 0.2%

NASDAQ DOCS opened at $43.70 on Friday. Doximity, Inc. has a 52 week low of $43.25 and a 52 week high of $85.21. The business’s fifty day simple moving average is $52.92 and its 200-day simple moving average is $60.66. The firm has a market cap of $8.23 billion, a PE ratio of 43.70, a P/E/G ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period last year, the company earned $0.30 earnings per share. Doximity’s revenue was up 23.2% on a year-over-year basis. Research analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

Doximity Company Profile

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.